The latest closing stock price for Apellis Pharmaceuticals as of November 07, 2024 is 28.74.
An investor who bought $1,000 worth of Apellis Pharmaceuticals stock at the IPO in 2017 would have $1,048 today, roughly 1 times their original investment - a 10.79% compound annual growth rate over 7 years.
The all-time high Apellis Pharmaceuticals stock closing price was 93.31 on June 13, 2023.
The Apellis Pharmaceuticals 52-week high stock price is 73.80, which is 156.8% above the current share price.
The Apellis Pharmaceuticals 52-week low stock price is 24.34, which is 15.3% below the current share price.
The average Apellis Pharmaceuticals stock price for the last 52 weeks is 47.05.
An investor who bought $1,000 worth of Apellis Pharmaceuticals stock at the IPO in 2017 would have $1,048 today, roughly 1 times their original investment - a 10.79% compound annual growth rate over 7 years.
The all-time high Apellis Pharmaceuticals stock closing price was 93.31 on June 13, 2023.
The Apellis Pharmaceuticals 52-week high stock price is 73.80, which is 156.8% above the current share price.
The Apellis Pharmaceuticals 52-week low stock price is 24.34, which is 15.3% below the current share price.
The average Apellis Pharmaceuticals stock price for the last 52 weeks is 47.05.